≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Leukaemia of unspecified cell type

Endpoint Browser PheWeb

CD2_LEUKAEMIA_NAS_EXALLC

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

None

-

2. Check conditions

None

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C95
  • Hospital discharge: ICD-9 — 20[7-8]
  • Hospital discharge: ICD-8 — 207
  • Hospital discharge: excluded ICD-9 — 207[0-8]
  • Hospital discharge: excluded ICD-8 — 207[0-2]
  • Cause of death: ICD-10 — C95
  • Cause of death: ICD-9 — 20[7-8]
  • Cause of death: ICD-8 — 207
  • Cause of death: excluded ICD-9 — 207[0-8]
  • Cause of death: excluded ICD-8 — 207[0-2]

2 out of 7 registries used, show all original rules.

-

4. Check minimum number of events

None

-

5. Include endpoints

None

-

6. Filter based on genotype QC (FinnGen only)

None

-

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF8
Parent code in ICD-10
C81-C96
Name in latin
Leuc(h)aemiae typo cellulari non specificato

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 303 132 171
Unadjusted period prevalence (%) 0.06 0.04 0.08
Median age at first event (years) 62.58 56.99 66.89

-FinnGen-

Age distribution of first events

0102030405060708005101520253035404550556065AgeIndividuals

-FinnGen-

Year distribution of first events

197019901995200020052010201520202023010203040506070YearIndividuals

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
298
Matched controls
2978
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
360.4
212.3
193
15
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
+∞
211.5
177
*
XW000
NOMESCO Finland
Bone marrow biopsy
122.0
150.6
155
26
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
133.7
118
*
C95.9
ICD-10 Finland
Leukaemia, unspecified
+∞
93.8
85
*
WW500
NOMESCO Finland
Blood transfusion
57.7
84.0
98
25
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
69.9
79.0
89
18
L03AA02
ATC
filgrastim; parenteral
+∞
68.4
63
*
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
+∞
65.0
60
*
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
+∞
59.4
55
*
A04AA01
ATC
ondansetron; systemic, rectal
40.5
59.1
74
24
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
565.5
49.9
48
*
A05AA02
ATC
ursodeoxycholic acid; oral
107.0
49.7
53
6
H02AB02
ATC
dexamethasone; systemic
67.0
48.5
55
10
127
Kela drug reimbursment
Transplant complication
72.8
48.2
54
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
9.1
47.9
114
189
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
15.0
45.4
79
70
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
44.9
42
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
16.6
43.5
72
56
J05AB11
ATC
valaciclovir; oral
8.5
41.2
100
166
ZX120
NOMESCO Finland
Intravenous
11.0
39.8
81
98
L01BB02
ATC
mercaptopurine; oral
83.2
39.1
43
6
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
67.5
36.2
41
7
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
35.1
33
*
9835/3-C42.1
ICD-O-3
Precursor cell lymphoblastic leukemia, NOS, of bone marrow
+∞
35.1
33
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
35.1
33
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
377.8
34.7
34
*
JN4BD
NOMESCO Finland
Extensive body CT
13.0
33.9
62
59
M04AA01
ATC
allopurinol; systemic
6.6
32.8
96
201
R50.9
ICD-10 Finland
Fever, unspecified
6.7
32.6
93
188
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
30.0
179
786
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
29.7
28
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.5
29.4
101
254
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
+∞
28.6
27
*
C95.1
ICD-10 Finland
Chronic leukaemia of unspecified cell type
+∞
28.6
27
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
6.9
27.6
75
139
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
+∞
27.5
26
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
12.5
26.2
48
45
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.5
25.8
44
35
L04AD01
ATC
ciclosporin; systemic
22.4
23.6
34
17
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
10.5
23.1
46
51
ZX090
NOMESCO Finland
Other technic of radiotherapy
129.9
22.9
24
*
WW200
NOMESCO Finland
Immunization
14.9
22.1
37
28
J01MA12
ATC
levofloxacin; systemic
4.4
21.5
90
267
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
23.7
21.3
30
14
L03AA13
ATC
pegfilgrastim; parenteral
+∞
21.1
20
*
L01XX05
ATC
hydroxycarbamide; oral
25.6
20.4
28
12
189
Kela drug reimbursment
Imatinib
+∞
20.0
19
*
121
Kela drug reimbursment
Severe hypofunction of sexual glands
21.2
19.9
29
15
J02AC03
ATC
voriconazole; systemic
213.5
19.8
20
*
TAB00
NOMESCO Finland
Lumbar puncture
9.2
19.8
42
52
D64.9
ICD-10 Finland
Anaemia, unspecified
5.4
19.7
63
140
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
18.9
18
*
L01XE01
ATC
[U] imatinib; oral
+∞
18.9
18
*
Z51.5
ICD-10 Finland
Palliative care
16.5
18.9
30
20
A41.9
ICD-10 Finland
Sepsis, unspecified
10.9
18.2
35
36
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
28.8
18.1
24
9
N02AA05
ATC
oxycodone; systemic
5.2
18.1
60
138
A03FA01
ATC
metoclopramide; systemic, rectal
4.5
17.8
68
182
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
53.3
17.2
20
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
16.4
17.0
27
18
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
8.9
16.8
36
45
115
Kela drug reimbursment
Breast cancer
+∞
16.8
16
*
B73
ICPC
Leukaemia
+∞
16.8
16
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
50.5
16.2
19
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.1
15.9
111
482
H02AB09
ATC
hydrocortisone; systemic
11.0
15.8
30
30
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
15.8
15
*
ZX121
NOMESCO Finland
Central venous catheter
+∞
15.8
15
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
15.8
15
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
168.4
15.6
16
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
14.7
14
*
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
+∞
14.7
14
*
C92.4
ICD-10 Finland
Acute promyelocytic leukaemia [PML]
+∞
14.7
14
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
14.7
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
157.3
14.6
15
*
ZX112
NOMESCO Finland
Subcutaneous
35.9
13.6
17
5
Z85.6
ICD-10 Finland
Personal history of leukaemia
+∞
13.6
13
*
J02AC04
ATC
posaconazole; systemic
+∞
13.6
13
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
13.6
13
*
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
+∞
13.6
13
*
TPH00
NOMESCO Finland
Phlebotomy
146.3
13.6
14
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
12.6
12
*
2AX04
NOMESCO Finland
NA
+∞
12.6
12
*
J05AB01
ATC
aciclovir; systemic
3.1
12.5
80
319
L04AA06
ATC
mycophenolic acid; systemic
14.2
12.1
20
15
J01MA14
ATC
moxifloxacin; systemic
4.4
11.9
44
112
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
67.6
11.7
13
*
JN4AD
NOMESCO Finland
Body CT examination
7.5
11.6
27
39
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
11.5
11
*
9811/3-C42.1
ICD-O-3
B lymphoblastic leukemia/lymphoma, NOS, of bone marrow
+∞
11.5
11
*
9801/3-C42.1
ICD-O-3
Acute leukemia, NOS, of bone marrow
+∞
11.5
11
*
130
Kela drug reimbursment
Malignant tumour
+∞
11.5
11
*
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
11.5
11
*
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
+∞
11.5
11
*
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
124.5
11.5
12
*
ZX131
NOMESCO Finland
Intrathecal
124.5
11.5
12
*
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
36.6
11.4
14
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
17.9
11.3
17
10
D70.82
ICD-10 Finland
Drug-induced neutropenia
26.2
11.2
15
6
ZX108
NOMESCO Finland
Inhalation
45.1
11.0
13
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
45.1
11.0
13
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.6
10.8
93
440
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.8
10.8
36
83
5BA08
NOMESCO Finland
NA
62.2
10.7
12
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
113.8
10.5
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
113.8
10.5
11
*
2089X
ICD-9 Finland
Leukaemia of unspecified cell type, Unspecified leukaemia
+∞
10.5
10
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
10.5
10
*
1DB06
NOMESCO Finland
NA
+∞
10.5
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.5
10
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
10.5
10
*
152
Kela drug reimbursment
Nilotinib
+∞
10.5
10
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
24.4
10.3
14
6
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
8.4
10.3
22
28
A07AA02
ATC
nystatin; oral
5.3
10.2
31
64
L02BA01
ATC
tamoxifen; oral
41.5
10.0
12
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
+∞
9.4
9
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
+∞
9.4
9
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
9.4
9
*
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
ZX114
NOMESCO Finland
Intramuscular
14.3
9.3
15
11
212
Kela drug reimbursment
Gout
10.5
9.1
17
17
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.5
9.1
82
393
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
6.5
9.1
23
38
H02AB04
ATC
methylprednisolone; systemic
3.0
9.1
56
215
N05BA06
ATC
lorazepam; systemic, sublingual
5.0
8.9
28
61
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
51.5
8.7
10
*
L02BG04
ATC
letrozole; oral
20.7
8.5
12
6
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.1
8.5
129
789
1XC02
NOMESCO Finland
NA
92.5
8.5
9
*
TPX15
NOMESCO Finland
Removal of vascular injection port
92.5
8.5
9
*
J02AC01
ATC
fluconazole; systemic
2.2
8.4
110
628
A41.8
ICD-10 Finland
Other specified sepsis
11.2
8.4
15
14
2AA01
NOMESCO Finland
NA
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
C93.0
ICD-10 Finland
Acute monoblastic/monocytic leukaemia
+∞
8.4
8
*
316
Kela drug reimbursment
Imatinib
+∞
8.4
8
*
L01XE06
ATC
[U] dasatinib; systemic
+∞
8.4
8
*
150
Kela drug reimbursment
Dasatinib
+∞
8.4
8
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
8.4
8
*
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
7.2
8.2
19
28
EP1AE
NOMESCO Finland
Neck ultrasound examination
5.6
8.2
23
44
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
3.4
8.2
40
131
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
8.2
35
103
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
34.3
8.1
10
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
6.0
8.0
21
37
R4110
NOMESCO Finland
Physiotherapy
2.4
8.0
79
394
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
13.5
7.9
13
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.2
7.7
89
478
B01AB05
ATC
enoxaparin; parenteral
2.2
7.6
85
450
L04AA01
ATC
[U] ciclosporin; systemic
10.4
7.6
14
14
B25.9
ICD-10 Finland
Cytomegaloviral disease, unspecified
82.0
7.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
82.0
7.4
8
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.9
7.4
30
84
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
WA010
NOMESCO Finland
Adjuvant whole body radiotherapy
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
7.3
7
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
7.3
7
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
7.3
7
*
L01XE08
ATC
[U] nilotinib; oral
+∞
7.3
7
*
1XX02
NOMESCO Finland
NA
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.7
7.3
31
91
ZZR00
NOMESCO Finland
Flap of skin
30.8
7.2
9
*
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
3.6
7.0
31
94
J01MA02
ATC
ciprofloxacin; systemic
2.0
6.8
113
702
6BA02
NOMESCO Finland
NA
41.0
6.8
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.7
40
151
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.6
6.7
29
87
QXB05
NOMESCO Finland
Skin wound assessment, unspecified location
71.3
6.4
7
*
D61.9
ICD-10 Finland
Aplastic anaemia, unspecified
71.3
6.4
7
*
B02.9
ICD-10 Finland
Zoster without complication
3.9
6.4
25
69
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.4
6.3
11
10
9866/3-C42.1
ICD-O-3
Acute promyelocytic leukemia, t(15;17)(q22;q11-12) of bone marrow
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
6.3
6
*
L01EA03
ATC
nilotinib; oral
+∞
6.3
6
*
C92.7
ICD-10 Finland
Other myeloid leukaemia
+∞
6.3
6
*
5AD01
NOMESCO Finland
NA
+∞
6.3
6
*
Y77
ICPC
Malignant neoplasm prostate
+∞
6.3
6
*
9800/3-C42.1
ICD-O-3
Leukemia, NOS, of bone marrow
+∞
6.3
6
*
9891/3-C42.1
ICD-O-3
Acute monocytic leukemia of bone marrow
+∞
6.3
6
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
6.3
6
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
6.3
6
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
6.3
6
*
1CX01
NOMESCO Finland
NA
+∞
6.3
6
*
A40.8
ICD-10 Finland
Other streptococcal sepsis
27.3
6.3
8
*
UGC12
NOMESCO Finland
Flexible bronchoscopy
3.6
6.2
27
81
HA1AA
NOMESCO Finland
X-ray mammography
6.3
6.1
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
86
26
45.79
139.21
5.8
1.6
—
—
—
0
0
71
11
83.99
132.06
1.3
1.3
—
—
—
0
0
71
12
76.97
130.15
2.6
2.5
—
—
—
0
0
74
16
60.87
129.50
1.2
1.2
—
—
—
0
0
77
35
29.15
108.21
1.4
1.1
—
—
—
0
0
87
67
17.81
95.44
1.3
1.3
—
—
—
0
0
75
43
22.85
95.30
1.3
1.1
247.79
183.33
u/ml
1.00
48
18
60
30
24.69
80.40
1.2
1.0
—
—
—
0
0
48
14
40.55
77.05
1.8
1.5
—
—
—
0
0
135
263
8.45
73.83
9.7
2.5
1.65
1.67
%
0.07
126
238
98
132
10.50
73.34
9.7
3.9
1.24
0.78
%
0.93
57
27
113
190
8.89
70.19
8.0
2.4
59.95
66.88
e9/l
0.91
90
158
41
11
42.95
67.03
1.7
1.5
3.07
2.82
mg/l
0.18
35
11
132
287
7.38
63.91
13.2
3.1
0.80
0.82
mmol/l
2.08
125
266
83
111
9.92
61.83
1.4
1.5
—
—
—
0
0
41
15
31.45
61.15
8.7
4.4
—
—
—
0
0
84
118
9.47
60.06
9.0
4.1
0.74
0.28
%
1.59
35
18
50
33
17.95
58.45
1.2
1.1
—
—
—
0
0
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
38
15
28.82
55.10
2.1
1.3
—
—
—
0
0
82
125
8.62
54.47
10.1
4.0
0.96
0.09
%
0.70
55
23
105
219
6.81
51.87
1.6
1.5
—
—
—
0
0
119
288
6.16
50.12
16.8
5.0
1.10
1.08
mmol/l
0.35
114
261
76
123
7.91
47.54
9.3
4.0
8.73
0.00
%
1.85
41
21
110
270
5.83
45.10
1.6
1.6
—
—
—
0
0
61
89
8.33
41.52
1.7
1.8
1.70
1.43
g/l
0.84
45
79
31
15
22.91
41.35
6.5
2.0
1.17
1.09
e9/l
—
18
10
79
162
6.24
38.86
3.7
1.7
63.72
67.12
g/l
2.82
74
140
175
731
4.30
35.01
26.8
5.0
—
—
—
0
0
146
543
4.26
34.20
14.9
3.6
—
—
—
0
0
26
13
21.78
34.05
5.0
2.1
10.08
10.75
%
—
12
8
147
556
4.19
33.50
10.6
2.3
306.99
5580.00
umol/l
2.07
142
490
110
349
4.38
31.67
1.6
1.9
—
—
—
0
0
37
42
9.90
30.45
7.8
1.2
—
—
—
0
0
24
15
17.29
28.29
1.6
2.5
34.43
52.09
%
—
7
7
40
56
8.08
27.83
1.6
1.3
—
—
—
0
0
193
995
3.59
25.67
27.1
5.0
0.58
0.68
%
1.11
188
917
197
1031
3.60
25.53
28.7
5.3
9.75
8.67
%
1.28
191
953
37
53
7.81
25.19
7.9
1.3
6.33
625.12
e6/l
0.97
27
43
37
53
7.81
25.19
7.9
1.2
1.46
3.52
e6/l
1.35
26
42
195
1024
3.54
24.92
27.5
5.0
2.16
2.97
%
7.46
190
942
198
1055
3.53
24.60
27.9
5.0
30.21
28.81
%
0.69
192
971
23
0
+∞
24.29
1.4
0.0
—
—
—
0
0
212
1213
3.49
22.74
46.5
6.1
3.23
4.27
e9/l
1.83
200
1048
198
1094
3.34
22.38
24.3
4.9
0.69
0.60
e9/l
0.20
186
934
21
16
14.03
22.18
1.0
1.0
—
—
—
0
0
198
1099
3.31
22.10
24.4
4.9
0.03
0.04
e9/l
5.77
185
939
135
602
3.24
21.95
12.2
2.0
—
—
—
0
0
199
1124
3.24
21.24
24.8
4.9
2.09
1.94
e9/l
0.19
188
977
200
1139
3.22
20.92
28.3
5.2
0.14
0.20
e9/l
6.50
186
993
167
866
3.07
20.50
16.9
3.7
33.52
35.82
g/l
5.68
162
802
24
26
9.94
20.24
10.2
1.2
—
—
—
0
0
21
19
11.80
19.98
6.6
1.0
—
—
—
0
0
53
135
4.55
19.64
2.6
1.3
—
—
—
0
0
132
612
3.05
19.61
13.0
2.9
7.41
7.40
ph
0.49
24
89
109
457
3.16
19.26
6.7
1.7
3.72
1.14
mg/l
1.52
96
350
169
907
2.95
19.08
15.0
3.6
—
—
—
0
0
108
454
3.14
18.95
11.1
2.0
—
—
—
0
0
104
429
3.17
18.84
14.0
4.1
—
—
—
0
0
177
981
2.93
18.70
20.9
5.6
1.20
1.22
mmol/l
1.30
168
880
22
5
47.27
18.50
5.6
1.2
—
—
—
0
0
186
1072
2.90
18.03
23.8
6.0
1.21
1.22
mmol/l
0.89
161
930
16
0
+∞
16.82
19.4
0.0
0.51
—
umol/l
—
16
0
19
6
33.63
14.99
6.4
1.5
0.18
0.17
e9/l
—
19
6
21
35
6.37
12.30
2.6
1.3
—
—
—
0
0
68
275
2.90
12.23
2.3
2.5
31.24
24.07
%
1.28
59
238
103
514
2.52
12.22
36.9
4.8
—
—
—
0
0
65
263
2.87
11.64
1.8
1.6
—
—
—
0
0
143
842
2.32
11.57
13.3
9.1
1.32
1.32
inr
0.00
40
216
17
24
7.44
11.54
4.7
1.5
35.35
34.00
pg
0.65
17
24
93
457
2.49
11.28
2.1
1.3
1.82
2.59
g/l
5.54
81
246
152
939
2.24
10.73
4.6
2.7
535.25
120.98
ug/l
6.84
143
858
117
650
2.30
10.67
5.1
2.2
52.24
57.12
u/l
0.98
112
596
105
559
2.34
10.56
1.9
2.2
3.22
2.93
mg/l
0.67
91
466
103
545
2.35
10.49
2.3
1.4
—
—
—
0
0
19
34
5.90
10.36
5.8
1.3
—
—
—
0
0
116
671
2.18
9.35
5.7
2.0
2.30
2.36
mmol/l
4.16
109
544
13
7
19.32
9.01
1.9
1.0
—
—
—
0
0
12
9
13.82
7.44
1.0
1.0
—
—
—
0
0
143
956
1.94
7.32
36.3
7.3
0.01
0.00
e9/l
0.56
124
758
7
0
+∞
7.32
1.9
0.0
13.71
—
%
—
7
0
16
35
4.77
7.01
9.3
2.7
47.56
57.60
%
1.07
16
35
60
297
2.27
6.86
2.0
1.9
—
—
—
0
0
35
141
2.68
6.21
6.7
4.9
—
—
—
0
0
189
1435
1.84
6.08
5.5
4.4
26.00
5329.36
e6/l
—
5
25
13
28
4.81
5.79
1.2
1.2
—
—
—
0
0
8
5
16.37
5.44
1.0
1.0
—
—
—
0
0
51
260
2.16
5.38
3.8
1.5
—
—
—
0
0
39
178
2.37
5.34
1.3
1.8
—
—
—
0
0
42
200
2.28
5.22
12.6
3.4
—
—
—
0
0
27
104
2.75
5.22
3.9
1.5
3.71
5.45
ug/l
0.24
22
81
99
646
1.79
5.07
2.4
1.6
—
—
—
0
0
45
224
2.18
5.03
11.3
8.2
94.69
94.93
%
0.08
40
215
73
436
1.89
4.95
1.9
1.7
1203.61
1147.73
nmol/l
0.20
64
331
74
444
1.88
4.95
3.9
2.3
4.19
5.33
e6/l
0.70
69
377
48
248
2.11
4.89
10.8
7.9
1.56
1.42
mmol/l
0.10
34
186
19
62
3.20
4.88
33.1
5.8
1.18
1.53
mg/l
1.48
19
56
11
24
4.72
4.82
1.0
1.1
—
—
—
0
0
17
53
3.34
4.69
2.4
1.8
9.38
6.45
u/l
0.50
11
47
71
429
1.86
4.62
3.9
2.5
574.20
567.54
mosm/kgh2o
0.09
66
345
8
8
10.23
4.54
1.5
1.0
—
—
—
0
0
9
12
7.69
4.38
1.2
1.3
—
—
—
0
0
7
6
11.90
4.29
1.6
1.2
87.57
55.33
mg/l
—
7
6
33
155
2.27
4.24
3.5
2.6
3.38
3.84
e9/l
0.29
28
116
95
643
1.70
4.16
4.6
3.1
—
—
—
0
0
96
653
1.69
4.12
5.4
3.0
41.39
159.87
e6/l
0.61
82
499
45
242
2.01
4.11
21.4
3.8
—
—
—
0
0
25
105
2.51
4.10
1.6
1.2
—
—
—
0
0
32
152
2.24
4.01
10.5
7.5
—
—
—
0
0
86
576
1.69
3.88
5.5
2.8
—
—
—
0
0
37
190
2.08
3.83
15.4
6.7
—
—
—
0
0
6
5
12.20
3.78
1.7
1.6
—
—
—
0
0
43
237
1.95
3.67
22.3
3.7
2.03
1.98
mmol/l
0.04
34
176
106
760
1.61
3.63
6.0
3.6
15.45
132.00
e6/l
2.43
85
531
44
247
1.91
3.56
10.0
7.9
4.86
5.12
kpa
0.99
39
236
6
6
10.17
3.51
1.2
1.0
—
—
—
0
0
86
598
1.61
3.30
5.6
2.9
0.23
0.43
e6/l
1.24
71
439
6
7
8.71
3.27
1.2
1.0
—
—
—
0
0
43
247
1.86
3.25
10.2
7.9
10.70
11.57
kpa
0.70
38
236
124
945
1.53
3.17
2.0
2.0
87.90
95.67
pmol/l
1.26
84
481
7
13
5.48
2.88
1.1
1.2
—
—
—
0
0
10
31
3.30
2.80
1.0
1.2
—
—
—
0
0
44
269
1.74
2.72
1.2
1.3
330.00
529.23
titre
—
8
65
8
19
4.29
2.69
1.0
3.0
—
—
—
0
0
32
178
1.89
2.68
3.5
3.1
—
—
—
0
0
114
879
1.48
2.65
3.9
3.8
57.97
40.93
ng/l
0.27
88
607
7
16
4.45
2.49
1.3
1.1
—
—
—
0
0
7
16
4.45
2.49
3.7
1.1
—
—
—
0
0
67
468
1.55
2.47
1.5
1.8
396.75
413.06
pmol/l
0.20
59
391
200
2242
0.68
2.47
4.9
4.9
2.66
2.70
mmol/l
0.30
189
2051
190
1633
1.44
2.40
5.5
4.0
18.87
11.27
mm/h
5.43
182
1492
108
839
1.45
2.37
3.1
3.5
—
—
—
0
0
14
59
2.44
2.33
8.4
3.0
—
—
—
0
0
7
18
3.95
2.26
1.0
1.0
—
—
—
0
0
10
37
2.76
2.12
4.3
2.5
—
—
—
0
0
70
510
1.48
2.11
3.5
3.5
—
—
—
0
0
21
110
1.98
2.11
18.0
11.9
—
—
—
0
0
196
2178
0.72
1.99
4.5
4.4
1.31
1.45
mmol/l
4.48
183
1994
26
150
1.80
1.98
1.8
1.1
—
—
—
0
0
31
189
1.71
1.97
1.3
1.3
—
—
—
0
0
238
2556
0.68
1.95
71.8
17.4
3.92
4.54
e12/l
26.01
233
2466
5
11
4.60
1.95
13.4
2.2
—
—
—
0
0
6
18
3.38
1.75
1.2
2.0
—
—
—
0
0
17
89
1.96
1.73
8.2
4.6
—
—
—
0
0
175
1530
1.34
1.73
6.1
4.1
—
—
—
0
0
5
13
3.89
1.72
1.6
1.2
—
—
—
0
0
6
19
3.20
1.67
1.7
1.2
1949.33
2633.00
e6/l
—
6
13
7
26
2.73
1.59
1.0
1.2
212.86
254.05
pmol/l
—
7
20
62
468
1.41
1.55
5.4
3.8
71.80
265.00
ng/l
1.79
54
377
7
28
2.53
1.46
1.0
1.3
—
—
—
0
0
13
66
2.01
1.45
1.5
1.1
—
—
—
0
0
200
2178
0.76
1.44
6.0
4.5
5.99
6.00
mmol/l
0.03
187
1963
6
23
2.64
1.37
2.5
2.3
—
—
—
0
0
5
17
2.97
1.36
1.8
1.2
136960.00
22161.44
e6/l
—
5
9
5
17
2.97
1.36
13.6
2.3
—
—
—
0
0
125
1071
1.28
1.32
3.4
3.6
0.00
0.00
estimate
0.00
18
176
203
2196
0.77
1.30
5.1
4.4
4.40
4.57
mmol/l
1.62
193
2019
38
271
1.46
1.30
2.4
2.2
125.45
121.23
ug/g
0.03
33
209
190
2071
0.78
1.28
4.8
4.4
2.14
2.52
mu/l
0.28
179
1873
17
101
1.72
1.22
10.7
7.8
23.21
24.74
mmol/l
0.94
12
90
5
19
2.66
1.22
2.8
3.3
—
—
—
0
0
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
5
19
2.66
1.22
1.4
1.2
—
—
—
0
0
126
1092
1.26
1.19
3.5
3.6
0.00
0.00
estimate
0.00
18
171
225
2393
0.77
1.18
35.0
11.4
—
—
—
0
0
5
21
2.40
1.09
1.0
1.5
—
—
—
0
0
59
726
0.77
1.04
2.9
3.0
—
—
—
0
0
123
1078
1.24
1.02
4.7
4.9
0.00
0.00
estimate
0.00
18
170
9
160
0.55
1.01
1.2
1.5
—
—
—
0
0
45
349
1.34
0.98
5.6
2.9
1.74
2.01
e6/l
0.13
27
190
0
30
0.00
0.98
0.0
1.0
—
1.28
—
0
15
69
570
1.27
0.95
3.6
3.8
0.00
0.00
estimate
0.00
19
167
41
315
1.35
0.95
22.6
24.6
1.36
1.32
inr
—
7
41
195
2089
0.81
0.94
5.0
5.9
39.40
40.24
mmol/mol
0.57
183
1930
6
29
2.09
0.90
1.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.0
—
4.47
—
0
14
0
27
0.00
0.78
0.0
1.0
—
0.55
—
0
10
10
59
1.72
0.76
3.2
2.2
24.20
24.38
mmol/l
—
10
49
14
204
0.67
0.71
1.2
1.4
—
—
—
0
0
17
236
0.70
0.68
1.5
1.7
—
—
—
0
0
164
1522
1.17
0.66
5.7
3.8
—
—
—
0
0
5
29
1.74
0.64
1.2
1.3
67.40
56.26
pmol/l
—
5
29
8
55
1.47
0.56
1.3
1.5
0.89
0.75
nmol/l
—
8
46
233
2414
0.85
0.54
37.5
8.2
30.38
26.15
u/l
2.38
227
2298
11
158
0.68
0.54
3.1
2.7
—
—
—
0
0
44
518
0.82
0.54
1.2
1.4
4.90
1.61
u/ml
—
10
127
200
2095
0.87
0.54
51.1
13.4
35.37
40.24
%
11.14
137
1521
58
665
0.84
0.54
2.9
3.1
1683.56
247.94
mg/l
0.66
44
433
62
703
0.85
0.50
3.4
3.9
11.71
8.17
mg/mmol
0.36
42
452
28
226
1.26
0.50
1.4
1.6
—
—
—
0
0
37
438
0.82
0.48
2.6
2.5
0.63
0.78
ug/l
0.84
26
274
7
48
1.47
0.47
69.6
3.0
—
—
—
0
0
34
284
1.22
0.46
1.2
1.2
—
—
—
0
0
10
140
0.70
0.44
1.2
1.2
81.00
104.37
iu/ml
—
5
52
9
128
0.69
0.44
1.8
2.5
—
—
—
0
0
32
379
0.83
0.43
1.3
1.3
12.71
34.22
iu/ml
—
9
118
5
32
1.57
0.42
1.4
3.4
—
—
—
0
0
69
620
1.15
0.42
5.2
3.9
—
—
—
0
0
0
15
0.00
0.41
0.0
1.7
—
—
—
0
0
11
79
1.41
0.41
1.9
3.0
0.39
0.21
g/l
—
5
27
11
79
1.41
0.41
1.4
1.1
—
—
—
0
0
5
36
1.40
0.38
2.8
1.3
—
—
—
0
0
23
189
1.23
0.37
1.4
1.4
—
—
—
0
0
6
41
1.47
0.36
2.3
2.0
—
—
—
0
0
203
2099
0.90
0.35
5.4
4.0
1.49
1.27
mmol/l
3.58
192
1912
11
82
1.35
0.34
1.3
1.2
—
—
—
0
0
234
2278
1.12
0.33
53.6
12.0
26.85
23.31
mg/l
0.71
222
1718
7
54
1.30
0.30
1.0
1.3
—
2.68
—
0
10
19
157
1.22
0.30
4.1
3.2
—
—
—
0
0
14
112
1.26
0.29
2.4
2.9
0.17
0.22
e6/l
0.19
14
107
17
204
0.82
0.28
1.3
1.2
—
—
—
0
0
12
96
1.26
0.25
2.6
1.7
—
—
—
0
0
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
6.70
—
0
11
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
0
10
0.00
0.21
0.0
7.5
—
—
—
0
0
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
150
1452
1.07
0.19
5.0
2.9
79.19
45.33
u/l
2.14
140
1341
69
730
0.93
0.18
2.6
3.0
6.53
7.61
mmol/l
1.19
62
616
6
76
0.79
0.16
1.7
1.7
—
—
—
0
0
6
78
0.76
0.15
1.0
1.2
—
1.37
—
0
7
7
86
0.81
0.15
1.0
1.4
—
—
—
0
0
7
86
0.81
0.15
1.0
1.4
—
—
—
0
0
7
87
0.80
0.14
1.0
1.4
—
—
—
0
0
16
141
1.14
0.14
1.2
1.2
—
—
—
0
0
13
113
1.16
0.13
45.0
2.5
1.40
1.16
%
0.54
13
113
10
115
0.87
0.11
2.4
3.4
—
—
—
0
0
5
46
1.09
0.09
1.6
1.7
137.60
129.90
g/l
—
5
31
5
46
1.09
0.09
2.2
1.3
4712.80
24664.63
e6/l
—
5
32
6
54
1.11
0.09
2.7
1.9
—
—
—
0
0
6
72
0.83
0.07
1.0
1.5
—
—
—
0
0
7
82
0.85
0.07
1.0
1.4
—
—
—
0
0
8
92
0.87
0.07
1.0
1.1
—
—
—
0
0
14
152
0.92
0.06
1.3
1.3
—
47.07
—
0
11
16
171
0.93
0.05
2.4
2.4
—
15.88
—
0
5
11
119
0.92
0.04
1.1
1.4
—
—
—
0
0
169
1702
0.98
0.03
4.1
3.6
14.91
14.82
pmol/l
0.18
156
1539
17
172
0.99
0.00
2.8
4.1
93.31
77.39
ng/l
0.65
17
150
59
592
1.00
0.00
2.8
3.1
—
—
—
0
0
36
359
1.00
0.00
1.2
1.3
3.26
11.66
u/ml
1.50
13
129
0
9
0.00
0.00
0.0
1.0
—
2.71
—
0
9
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
18.23
—
0
6
0
7
0.00
0.00
0.0
1.4
—
44.43
—
0
7
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
12.0
—
7.07
—
0
5
7
77
0.91
0.00
10.3
10.2
—
—
—
0
0
6
69
0.87
0.00
2.3
2.3
66.00
82.10
ug/min
—
6
41
0
5
0.00
0.00
0.0
1.0
—
166.80
—
0
5
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
8
85
0.94
0.00
1.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: CD2_LEUKAEMIA_NAS_EXALLC – Leukaemia of unspecified cell type

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).